University Hospitals joins TriNetX Network for clinical research prospects

By Maggie Lynch

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)
University Hospitals Cleveland Medical Center has joined the TriNetX network to increase its research opportunities while benefitting the network of real world evidence and data.

By joining TriNetX, a global health research network, University Hospitals Cleveland Medical Center, a 1,302-bed medical center in Cleveland, OH, aims to refine its study opportunity process by allowing TriNetX to query its electronic medical records (EMR).

As part of the TriNetX network, University Hospitals also will provide opportunities for its investigators to collaborate with other academic centers, and increase the ability for the university hospital system to acquire industry and multi-centered studies.

Steve Lethbridge, senior vice president, global data networks at TriNetX told us, “The addition of University Hospitals Cleveland Medical Center brings an additional 1.5m lives to the TriNetX network, including oncology and pediatric patients, and enables our pharma and CRO members to collaborate on research opportunities with one of the largest and most prestigious clinical research centers in the US.”

University Hospital Cleveland Medical Center includes UH Rainbow Babies & Children’s Hospital, UH MacDonald’s Women’s Hospital, and UH Seidman Cancer Center.

Other organizations which have recently joined TriNetX’s network include: Pfizer​, Tufts University​, Allergan​, and Sanofi​.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars